BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19232734)

  • 1. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
    Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
    Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
    Hamada S; Kersey T; Thaller VT
    Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small margin excision of periocular basal cell carcinomas.
    Chadha V; Wright M
    Br J Ophthalmol; 2009 Jun; 93(6):803-6. PubMed ID: 19304655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic safety margins of periocular BCC.
    Rumelt S
    Ophthalmology; 2010 Feb; 117(2):403-4; author reply 404. PubMed ID: 20141864
    [No Abstract]   [Full Text] [Related]  

  • 6. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
    Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
    Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
    Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
    Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure.
    Morris DS; Elzaridi E; Clarke L; Dickinson AJ; Lawrence CM
    Br J Ophthalmol; 2009 Apr; 93(4):474-6. PubMed ID: 19060015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do basal cell carcinomas recur after complete conventional surgical excision?
    Griffiths RW; Suvarna SK; Stone J
    Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
    Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
    Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low 5-year recurrence rate after surgical excision of 126 basal cell carcinomas with frozen section analysis upon indication].
    van der Meer GT; Willemse F; Marck KW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1409-13. PubMed ID: 11494691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal cell carcinoma.
    Cannon PS; Huilgol SC; Selva D; Malhotra R
    Ophthalmology; 2009 Nov; 116(11):2266-7; author reply 2267. PubMed ID: 19883865
    [No Abstract]   [Full Text] [Related]  

  • 15. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excision of periocular basal cell carcinoma with stereoscopic microdissection of surgical margins for frozen-section control: report of 200 cases.
    Levin F; Khalil M; McCormick SA; Della Rocca D; Maher E; Della Rocca RC
    Arch Ophthalmol; 2009 Aug; 127(8):1011-5. PubMed ID: 19667338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.
    Cook BE; Bartley GB
    Ophthalmology; 1999 Apr; 106(4):746-50. PubMed ID: 10201597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of excision of 1750 eyelid and periocular skin basal cell and squamous cell carcinomas by modified en face frozen section margin-controlled technique.
    Gayre GS; Hybarger CP; Mannor G; Meecham W; Delfanti JB; Mizono GS; Guerry TL; Chien JS; Sooy CD; Anooshian R; Simonds R; Pietila KA; Smith DW; Dayhoff DA; Engman E; Lacy J
    Int Ophthalmol Clin; 2009; 49(4):97-110. PubMed ID: 20348860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.